Latest Partnerships News

Bio-Gene Technology Limited has secured A$3 million in U.S. Department of Defense grants to accelerate development of its two nature-derived insecticides, Flavocide and Qcide, targeting both military and civilian markets.

Pro Medicus has inked a $53 million, seven-year contract with BayCare to deploy its Visage 7 cloud-based imaging platform across Florida’s largest healthcare system, marking a major step in its North American expansion.

AKORA Resources has raised $1.293 million through a strategic share placement involving its first institutional investor and full board participation, aiming to advance logistics and investor discussions for its Bekisopa iron ore project.

Vmoto reports a 33% decline in FY24 unit sales but maintains operational cash flow positivity and secures new joint ventures in Thailand and Mexico to bolster its electric mobility footprint.

Kingsgate Consolidated Limited celebrates a key production milestone at its Chatree Gold Mine with the 100th gold pour since March 2023, alongside rising head grades and ore volumes exceeding forecasts.

Wellnex Life has secured Therapeutic Goods Administration approval for its Liquid Paracetamol plus Caffeine Soft Gel, marking its fourth market authorisation and opening new revenue avenues.

Viridis Mining and Minerals has raised A$3.5 million through a placement to fund critical development milestones for its Colossus Rare Earth Element project, following a major resource upgrade.

Predictive Discovery Limited has raised A$69.2 million through a strategic placement with the Lundin Family and Zijin Mining, bolstering its financial position to advance the Bankan Gold Project in Guinea.

Canyon Resources has gained government approval for its Inland Rail Facility location in Cameroon, advancing the Minim Martap Bauxite Project with new land allocation and infrastructure plans.

Intelligent Monitoring Group has secured a $122.5 million debt facility with National Australia Bank, halving its interest rate and freeing up capital for growth. This refinancing marks a pivotal step in the company’s strategic expansion plans.

Rhythm Biosciences has fast-tracked the integration of the geneType™ business, restoring full commercial capabilities ahead of schedule and setting the stage for expanded market reach.

Nufarm’s 2025 AGM revealed a resilient FY24 performance despite industry headwinds, with strategic investments in omega-3 canola, biofuels, and cost-saving initiatives setting the stage for growth in FY25.